Table 1. Protein immunoreactivity between HCTs and PLTs.
| HCCs (n = 33) | PLTs (n = 33) | ||||||
|---|---|---|---|---|---|---|---|
| Protein | Immunoreactivity | Percentage | Total score | Average score | Percentage | Total score | Average score |
| IQGAP1 | - | 12.12% (4/33) | 0 | 0 | 15.15% (5/33) | 0 | 0 |
| + | 27.27% (9/33) | 20 | 2.22±0.22 | 45.45% (15/33) | 31 | 2.07±0.21 | |
| ++ | 24.24% (8/33) | 40 | 5.00±0.38 | 30.30% (10/33) | 48 | 4.80±0.33 | |
| +++ | 36.36% (n = 33) | 128 | 10.67±0.48 | 9.09% (3/33) | 25 | 8.33±0.33 | |
| β-catenin | - | 15.15% (5/33) | 0 | 0 | 24.24% (8/33) | 0 | 0 |
| + | 27.27% (9/33) | 19 | 2.11±0.26 | 36.67% (12/33) | 22 | 1.83±0.21 | |
| ++ | 24.24% (8/33) | 38 | 4.75±0.37 | 27.27% (9/33) | 40 | 4.44±0.29 | |
| +++ | 33.33% (11/33) | 115 | 10.45±0.55 | 12.12% (4/33) | 33 | 8.25±0.25 | |
* Student’s t test, p< 0.05.
HCTs: hepatocellular carcinoma tissues. PLTs: para-cancerous liver tissues.
Percentage: (specific case/total cases)
-: negative expression
+: weak expression
++: moderate expression
+++: Overexpression.